Toby Eyre

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Toby Eyre
Aug 24, 2024, 06:55 | Insight
Jaimal Kothari: The first ever study looking at checkpoint inhibition in WM
Recently, an article by Jaimal Kothari et al. titled "PembroWM: A phase II trial to…
Aug 14, 2024, 07:49 | Insight
New LBCL CNS prophylaxis guidelines by Matt Wilson et al.
Ajay Major, Assistant Professor at the University of Colorado School of Medicine, shared on X:…
Aug 12, 2024, 13:10 | Insight
Matt Wilson: Updated good practice paper on CNS prophylaxis in LBCL
Matt Wilson, Consultant Haematomogist specialising in lymphoma at The Beatson West of Scotland Cancer Centre,…
Jul 8, 2024, 10:45 | Blog
Treatment of Chronic Lymphocytic Leukemia and Richter's transformation - VJHemOnc
VJHemOnc shared a post on X: “Do not miss out on our recent session from…
Jun 19, 2024, 11:49 | Blog
Toby Eyre: Epcoritamab monotherapy in patients with lymphoma by Kim M Linton et al
Toby Eyre, CLL specialist at Oxford University Hospitals, shared on X: "Epcoritamab monotherapy in patients with…
Jun 17, 2024, 07:05 | Societies
15 Posts You Should Not Miss From EHA 2024!
The European Hematology Association (EHA) Hybrid Congress or EHA2024 will took place in Madrid, Spain…
May 18, 2024, 04:13 | Insight
Toby Eyre: Important primary analysis of UK MCL biobank at EHA2024
Toby Eyre, CLL specialist at Oxford University Hospitals, shared on X: “Look out for important…
Dec 5, 2023, 12:57 | Drugs
Toby Eyre: Big news in CLL
Toby Eyre, CLL specialist at Oxford University Hospitals, announced on X/Twitter: "Big news in CLL.…
All: 8 Posts: 1 - 100
Special Coverage